Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C
Cancer. 1983 May 15;51(10):1941-3. doi: 10.1002/1097-0142(19830515)51:10<1941::aid-cncr2820511032>3.0.co;2-t.
A multicentric randomized trial evaluated the interest of internal mammary dissection on operable breast cancer patients. One thousand four hundred and fifty-three patients were included in the study and were followed for ten years. There is no difference in survival or in relapse-free survival between the two groups. There were significantly more local recurrences in the group without internal mammary dissection, but these recurrences occurred mainly on patients who developed metastases. A great difference between centers was observed in the number of nodes examined and there is therefore a difference in the prognostic value of the number of nodes invaded.